Page last updated: 2024-10-24

carbazilquinone and Alopecia

carbazilquinone has been researched along with Alopecia in 1 studies

Carbazilquinone: An alkylating agent structurally similar to MITOMYCIN and found to be effective in the treatment of leukemia and various other neoplasms in mice. It causes leukemia and thrombocytopenia in almost all human patients.

Alopecia: Absence of hair from areas where it is normally present.

Research Excerpts

ExcerptRelevanceReference
"The relapse rate of bladder cancer (transitional cell Ca) is said to be about 45%-80% even after tumor resection."1.27Evaluation of multidisciplinary treatment of bladder cancer, especially in chemoimmunotherapy (ADM and OK-432) as a consolidation therapy. ( Chin, H; Hiraoka, Y; Minowa, T; Nakagami, Y; Tozuka, K, 1983)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakagami, Y1
Minowa, T1
Tozuka, K1
Hiraoka, Y1
Chin, H1

Other Studies

1 other study available for carbazilquinone and Alopecia

ArticleYear
Evaluation of multidisciplinary treatment of bladder cancer, especially in chemoimmunotherapy (ADM and OK-432) as a consolidation therapy.
    Cancer chemotherapy and pharmacology, 1983, Volume: 11 Suppl

    Topics: Adjuvants, Immunologic; Aged; Alopecia; Biological Products; Carbazilquinone; Carcinoembryonic Antig

1983